Home » Topics » BioWorld Science

BioWorld Science
RSS

Ortec's OrCel approved for healing donor site wounds in burn victims

Sep. 10, 2001

HGS initiates new clinical trial with repifermin for treatment of mucositis

Sep. 10, 2001

Orally active NO-independent sGC stimulators from Bayer with vasodilating and hypotensive activity

Sep. 10, 2001

Positive results obtained in phase II Chronogesic trial for long-term pain relief

Sep. 10, 2001

Jomed and Oxigene form collaboration on restenosis inhibitors

Sep. 10, 2001

Zeria licenses rights to Visicol from InKine

Sep. 10, 2001

Glucose excursion decreased, formation of new beta-cells enhanced by DPP IV inhibitor

Sep. 10, 2001

Antidiabetic effects of GW-0072, a new SPARM, examined in animal model of type 2 diabetes

Sep. 10, 2001

BTG obtains rights to ANF peptide technology from Genentech

Sep. 10, 2001

Simplified salicylihalimide analogues which retain antitumor activity

Sep. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...